Cara Therapeutics | CARA - Action





Action Changement Date
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Cara Therapeutics USD 900K 0 2025-03
Chugai Pharma JPY 276.85B 30.52B 2025-12
Cipla INR 65.97B 4.37B 2026-03
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
J&J USD 15.14B 561M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Pacira USD 134.57M 15.8M 2026-06
Pfizer USD 9.94B 722M 2026-06
RedHill Biopharma USD 3.17M 482K 2025-06
Supernus Pharmaceuticals USD 107.03M 3.74M 2026-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12